Effects of genetic variation in protease activated receptor 4 after an acute coronary syndrome: Analysis from the TRACER trial
Keywords: PAR; protease activated receptor; NSTE ACS; non-ST-segment elevation acute coronary syndromes; TRACER; Thrombin Receptor Antagonist for Clinical Event Reduction; Platelets; PAR1; PAR4; Bleeding; Pharmacogenetics;